DONNA ORTIZ: Open Payments
NPI 1114569431 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228,932 in 390 payments from 11 companies in 2025. Trend: 2023 $57,971 · 2024 $92,309 · 2025 $228,932
Speaker / faculty: $169,160Travel & lodging: $27,408Consulting: $13,923Honoraria: $11,570Food & beverage: $6,872
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 121 | $105,555 |
| Lilly USA, LLC | 142 | $80,612 |
| ABBVIE INC. | 65 | $19,703 |
| Celltrion USA Inc. | 32 | $15,551 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $4,044 |
| Eli Lilly and Company | 6 | $3,332 |
| Janssen Scientific Affairs, LLC | 1 | $38 |
| PFIZER INC. | 2 | $30 |
| Sandoz Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: TREMFYA, OMVOH, ZYMFENTRA, SKYRIZI, RINVOQ, STELARA, ENTYVIO, VEGZELMA.
Industry payments across FL — which companies pay providers there.
